Merck (MRK) Tops Q2 EPS by 14c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $146.87 -0.19%
EPS Growth %: -14.0%
Financial Fact:
Sales: 23.64B
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -14.0%
Financial Fact:
Sales: 23.64B
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q2 EPS of ($0.13), $0.14 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $16.6 billion versus the consensus estimate of $16.41 billion.
GUIDANCE:
Merck sees FY2026 EPS of $2.66-$2.76, versus the consensus of $2.76.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kepler Cheuvreux Downgrades Volkswagen AG (VOW:GR) (VWAGY) to Hold
- Rothschild Redburn Starts Terawulf Inc. (WULF) at Neutral
- Rothschild Redburn Starts Iron Mountain (IRM) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
